Over The Counter Market
PUBLISHED: 2024 ID: SMRC25199
SHARE
SHARE

Over The Counter Market

Over the Counter Market Forecasts to 2030 - Global Analysis By Product (Analgesics, Digestives & Intestinal Remedies, Cold & Cough Remedies, Vitamins & Minerals, Dermatological Products and Other Products), Dosage Form (Tablets, Ointments, Liquids, Sprays and Other Dosage Forms), Route of Administration, Distribution Channel, End User and By Geography

4.6 (44 reviews)
4.6 (44 reviews)
Published: 2024 ID: SMRC25199

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $173.34 BN

Projected Year Value (2030)

US $278.34 BN

CAGR (2023 - 2030)

7%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Over the Counter Drug Market is accounted for $173.34 billion in 2023 and is expected to reach $278.34 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Over-the-Counter (OTC) drugs refer to medications that are available for purchase without a prescription from a healthcare professional. These drugs play a crucial role in providing accessible and convenient solutions for consumers to address minor health issues like common cold, body pain, allergies and flu, heartburn, acne, and other basic health problems. Acetaminophen, aspirin, antacids, decongestants, antihistamines, and laxatives are the examples of OTC drugs. These drugs are chosen by regulatory agencies in many countries to guarantee that they contain chemicals that are safe and effective when taken without the supervision of a physician. 

According to a National Institute of Health report, 93% of adults in the U.S. prefer to treat minor illnesses with over the counter drugs before seeking professional help, and 85% of parents prefer to treat minor illnesses in their children with over the counter drugs before seeking professional help.

Market Dynamics: 

Driver: 

Growing demand for self-medications

Self-medication becomes increasingly popular as people explore readily accessible remedies without a prescription. These medications are readily available in pharmacies, supermarkets, convenience stores, and increasingly through online platforms. This accessibility allows consumers to easily purchase medications for minor ailments and everyday health concerns. Moreover, affordability is a key advantage of OTC drugs compared to prescription medications. With a focus on affordability and ease of access, the market benefits from consumers' preference for managing minor health issues on their own, contributing to the overall growth of the OTC Drug Market.

Restraint:

Safety concerns

OTC drugs, available without a prescription, pose risks of misuse, abuse, and adverse effects due to self-administration by consumers. As individuals may lack professional medical guidance, there's an increased potential for incorrect dosage, drug interactions, or reliance on OTC options for conditions requiring professional intervention. This raises regulatory scrutiny to ensure consumer safety. Instances of adverse reactions or safety issues may result in product recalls or restrictions, impacting market dynamics.

Opportunity:

Global aging population

As the world's population ages, there is a concurrent increase in the prevalence of age-related health issues and chronic conditions. OTC drugs cater to the rising demand for self-medication among the elderly, offering accessible and cost-effective solutions for common ailments. Moreover, aging is often associated with various health concerns, such as joint pain, arthritis, cardiovascular issues, and digestive problems. OTC drugs provide a convenient solution for managing these common ailments without the need for a prescription. OTC products, including vitamins, supplements, and wellness-focused medications, align with the trend of maintaining overall health and preventing age-related issues. 

Threat:

Competition from generic drugs

The introduction of generic substitutes, which are frequently less expensive than branded over-the-counter medications, increases market rivalry and put well-known companies under pressure. Generic options, while meeting regulatory standards, can erode profit margins and diminish the market share of branded OTC drugs. Also, the branded OTC drugs may lose their exclusivity as generic options become available, leading to a reduction in market exclusivity and potentially impacting the sales and revenue of the original products.

Covid-19 Impact

Increased health awareness, preventive measures, and heightened demand for self-care products during the pandemic led to a surge in OTC sales. Consumers sought remedies for common symptoms, boosting sales of immune boosters, cough and cold medications, and hygiene-related products. However, disruptions in the supply chain, changes in consumer spending patterns, and economic uncertainties also presented challenges. The pandemic underscored the importance of adaptability and innovation in the OTC industry, shaping new trends in consumer behaviour and market dynamics.

The analgesics segment is expected to be the largest during the forecast period

The analgesics segment is estimated to hold the largest share. Analgesics are medications used in the management and treatment of pain. Widely used to alleviate mild to moderate pain, analgesics include common OTC drugs such as acetaminophen, ibuprofen, and aspirin. These medications addresses a broad spectrum of pain conditions, including headaches, muscle pain, menstrual cramps, and minor arthritis pain. The analgesics segment is characterized by its accessibility ease of use, and broad consumer acceptance, contributing significantly to the overall OTC drug market's growth

The tablets segment is expected to have the highest CAGR during the forecast period

The tablets segment is anticipated to have lucrative growth during the forecast period. Tablets are solid, compressed forms of medication, containing active ingredients along with various excipients. Tablets offer precise dosage control, with each tablet containing a standardized amount of the active ingredient. This ensures consistency in dosing and helps consumers follow recommended usage guidelines. Moreover, they cater to various therapeutic areas, addressing conditions like pain, allergies, digestive issues, and nutritional deficiencies. The convenience, precision in dosing, and broad range of medications available in tablet form contribute to their widespread use and popularity in the OTC drug market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing healthcare awareness, rising disposable incomes, and a growing population. There's a notable trend towards self-medication, driven by factors such as busy lifestyles, easy access to information, and a preference for non-prescription solutions. Moreover, preferences and buying behaviours vary across countries due to cultural differences, healthcare practices, and historical factors. Understanding these nuances is essential for companies aiming to establish a strong presence in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. Consumers in North America often prefer self-care and over-the-counter solutions for common health issues. This trend is driven by factors like convenience, accessibility, and the desire to manage minor ailments without the need for a prescription. The regulatory environment in North America is well-defined, with the U.S. Food and Drug Administration (FDA) and Health Canada overseeing the approval and regulation of OTC drugs. Furthermore, the North American OTC market is highly competitive, with both domestic and multinational pharmaceutical companies vying for market share.  

Key players in the market

Some of the key players in the Over the Counter Drug Market include Bayer AG, Pfizer, Takeda Pharmaceutical Company Ltd., Johnson & Johnson Services Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Boehringer Ingelheim International GmbH, Mylan, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Cipla Inc., Glenmark Pharmaceuticals Ltd, Dr. Reddy's Laboratories, Alkem Laboratories Limited, Viatris, Inc, The Blackstone Group, Inc., Aytu Biopharma, Inc. and Merck & Co. Inc.

Key Developments:

In June 2022, Glenmark Pharmaceuticals Ltd. acquired a portfolio of approved OTC abbreviated new drug applications (ANDAs) in the U.S. from Wockhardt. The acquired ANDAs helped the company expand its OTC portfolio in the U.S.

In June 2021, Bayer announced the approval of Astepro Allergyfrom the U.S. Food and Drug (FDA) as an over the counter (OTC) product for the temporary relief of nasal congestion runny nose and Itchy nose and other respiratory allergies.

Products Covered:
• Analgesics 
• Digestives & Intestinal Remedies 
• Cold & Cough Remedies 
• Vitamins & Minerals 
• Dermatological Products 
• Other Products 

Dosage Forms Covered:
• Tablets
• Ointments
• Liquids
• Sprays
• Other Dosage Forms

Route of Administrations Covered:
• Oral
• Parenteral
• Topical
• Other Routes of Administration

Distribution Channels Covered:
• Drug Stores & Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies

End Users Covered:
• Speciality Clinic
• Hospital
• Homecare
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary     
       
2 Preface      
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.6 Product Analysis    
 3.7 End User Analysis    
 3.8 Emerging Markets    
 3.9 Impact of Covid-19    
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Over the Counter Drug Market, By Product  
 5.1 Introduction    
 5.2 Analgesics    
 5.3 Digestives & Intestinal Remedies  
 5.4 Cold & Cough Remedies   
 5.5 Vitamins & Minerals   
 5.6 Dermatological Products   
 5.7 Other Products    
       
6 Global Over the Counter Drug Market, By Dosage Form 
 6.1 Introduction    
 6.2 Tablets     
 6.3 Ointments    
 6.4 Liquids     
 6.5 Sprays     
 6.6 Other Dosage Forms   
       
7 Global Over the Counter Drug Market, By Route of Administration
 7.1 Introduction    
 7.2 Oral     
 7.3 Parenteral    
 7.4 Topical     
 7.5 Other Routes of Administration  
       
8 Global Over the Counter Drug Market, By Distribution Channel
 8.1 Introduction    
 8.2 Drug Stores & Retail Pharmacies  
 8.3 Online Pharmacies    
 8.4 Hospital Pharmacies   
       
9 Global Over the Counter Drug Market, By End User  
 9.1 Introduction    
 9.2 Speciality Clinic    
 9.3 Hospital     
 9.4 Homecare    
 9.5 Other End Users    
       
10 Global Over the Counter Drug Market, By Geography 
 10.1 Introduction    
 10.2 North America    
  10.2.1 US    
  10.2.2 Canada    
  10.2.3 Mexico    
 10.3 Europe     
  10.3.1 Germany    
  10.3.2 UK    
  10.3.3 Italy    
  10.3.4 France    
  10.3.5 Spain    
  10.3.6 Rest of Europe   
 10.4 Asia Pacific    
  10.4.1 Japan    
  10.4.2 China    
  10.4.3 India    
  10.4.4 Australia    
  10.4.5 New Zealand   
  10.4.6 South Korea   
  10.4.7 Rest of Asia Pacific   
 10.5 South America    
  10.5.1 Argentina   
  10.5.2 Brazil    
  10.5.3 Chile    
  10.5.4 Rest of South America  
 10.6 Middle East & Africa   
  10.6.1 Saudi Arabia   
  10.6.2 UAE    
  10.6.3 Qatar    
  10.6.4 South Africa   
  10.6.5 Rest of Middle East & Africa  
       
11 Key Developments     
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers   
 11.3 New Product Launch   
 11.4 Expansions    
 11.5 Other Key Strategies   
       
12 Company Profiling     
 12.1 Bayer AG     
 12.2 Pfizer     
 12.3 Takeda Pharmaceutical Company Ltd.  
 12.4 Johnson & Johnson Services Inc.  
 12.5 Novartis AG    
 12.6 Sanofi S.A.    
 12.7 GlaxoSmithKline PLC   
 12.8 Reckitt Benckiser Group PLC   
 12.9 Boehringer Ingelheim International GmbH 
 12.10 Mylan     
 12.11 Sun Pharmaceutical Industries Ltd  
 12.12 Teva Pharmaceutical Industries Ltd  
 12.13 Cipla, Inc     
 12.14 Glenmark Pharmaceuticals Ltd   
 12.15 Dr. Reddy's Laboratories   
 12.16 Alkem Laboratories Limited   
 12.17 Viatris, Inc    
 12.18 The Blackstone Group, Inc.   
 12.19 Aytu Biopharma, Inc.   
 12.20 Merck & Co. Inc.    
       
List of Tables      
1 Global Over the Counter Drug Market Outlook, By Region (2021-2030) ($MN)
2 Global Over the Counter Drug Market Outlook, By Product (2021-2030) ($MN)
3 Global Over the Counter Drug Market Outlook, By Analgesics (2021-2030) ($MN)
4 Global Over the Counter Drug Market Outlook, By Digestives & Intestinal Remedies (2021-2030) ($MN)
5 Global Over the Counter Drug Market Outlook, By Cold & Cough Remedies (2021-2030) ($MN)
6 Global Over the Counter Drug Market Outlook, By Vitamins & Minerals (2021-2030) ($MN)
7 Global Over the Counter Drug Market Outlook, By Dermatological Products (2021-2030) ($MN)
8 Global Over the Counter Drug Market Outlook, By Other Products (2021-2030) ($MN)
9 Global Over the Counter Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
10 Global Over the Counter Drug Market Outlook, By Tablets (2021-2030) ($MN)
11 Global Over the Counter Drug Market Outlook, By Ointments (2021-2030) ($MN)
12 Global Over the Counter Drug Market Outlook, By Liquids (2021-2030) ($MN)
13 Global Over the Counter Drug Market Outlook, By Sprays (2021-2030) ($MN)
14 Global Over the Counter Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
15 Global Over the Counter Drug Market Outlook, By Route of Administration (2021-2030) ($MN)
16 Global Over the Counter Drug Market Outlook, By Oral (2021-2030) ($MN)
17 Global Over the Counter Drug Market Outlook, By Parenteral (2021-2030) ($MN)
18 Global Over the Counter Drug Market Outlook, By Topical (2021-2030) ($MN)
19 Global Over the Counter Drug Market Outlook, By Other Routes of Administration (2021-2030) ($MN)
20 Global Over the Counter Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
21 Global Over the Counter Drug Market Outlook, By Drug Stores & Retail Pharmacies (2021-2030) ($MN)
22 Global Over the Counter Drug Market Outlook, By Online Pharmacies (2021-2030) ($MN)
23 Global Over the Counter Drug Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
24 Global Over the Counter Drug Market Outlook, By End User (2021-2030) ($MN)
25 Global Over the Counter Drug Market Outlook, By Speciality Clinic (2021-2030) ($MN)
26 Global Over the Counter Drug Market Outlook, By Hospital (2021-2030) ($MN)
27 Global Over the Counter Drug Market Outlook, By Homecare (2021-2030) ($MN)
28 Global Over the Counter Drug Market Outlook, By Other End Users (2021-2030) ($MN)
       
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials